QlikView User Report Dr. Loges & Co.
Pharmaceutical Manufacturer Dr. Loges + Co. combines classical accounting with cost accounting using QlikView
QlikView was successfully installed at the Dr. Loges pharmaceutical company within two weeks. It allows the drug manufacturer to obtain a clear and up-to-date presentation of results at the purchaser level, providing the basis for future strategic decisions.
According to Torsten Rustmann, the commercial director of Dr. Loges, significant staffing and time was previously required in order to prepare individual key figures. Other challenges when implementing QlikView were:
- Special three-stage breakeven analysis for strategic business segment considerations
- Heavy investment of time and high error rate in the derivation of the key figures in Excel
- Inadequate results display options in Microsoft Dynamics NAV
After just two weeks, the drug manufacturer was able to benefit from the following advantages:
- significant time savings when deriving the data
- high level of data transparency and information security
- current daily figures
- Presentation of results with cost object reference at the push of a button
Excel is too complex and insecure for the high controlling requirements of Dr. Loges
A quote from Commercial Director, Thorsten Rustmann, following the successful introduction of QlikView at Dr. Loges:
With QlikView, we have the option of analysing our business, not only by type of cost but also with the cost object in view simultaneously. And we are able to do that without having to derive the figures from Excel in an expensive and insecure manner.
Previously we had to ask: "How do I generate the numbers?" Today we can focus on the actual key question: "What do the numbers tell us?"
Obtaining direct, experience-based information about the solution from users in various industries was ideal for our decision-making and it finally convinced us that QlikView was exactly the right product for us.
Share this page
